Characterization of hepatic cytochrome P4503A activity in patients with end‐stage renal disease View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2003-05

AUTHORS

Thomas C. Dowling, Andrew E. Briglia, Jeffrey C. Fink, Donna S. Hanes, Paul D. Light, Lucy Stackiewicz, Chetan S. Karyekar, Natalie D. Eddington, Matthew R. Weir, William L. Henrich

ABSTRACT

BACKGROUND: The cytochrome p450 (CYP) oxidative enzyme system, located primarily in the liver and small intestine, is responsible for metabolism and detoxification of numerous endogenous and exogenous substances. The most abundant CYP enzyme, CYP3A, is known to be involved in the metabolism of more than 200 commonly used medications. In experimental models of renal failure, both hepatic function and CYP enzyme content are reduced; however, direct evidence in humans is lacking. Evaluation of drug metabolism in patients with end-stage renal disease is important because these patients use a large number of medications and are at risk of adverse reactions and drug-drug interactions. METHODS: We measured hepatic CYP3A activity at baseline and after rifampin (INN, rifampicin) enzyme induction in 12 patients with end-stage renal disease and 12 healthy, age-matched controls. Hepatic CYP3A phenotype was characterized with the erythromycin breath test, and enzyme induction capacity was evaluated with a short course of rifampin (600 mg/d for 6 days). RESULTS: The end-stage renal disease group had 28% lower baseline erythromycin breath test values than controls (P <.05); however, enzyme induction capacity after rifampin administration was similar between groups (P =.70). CONCLUSION: The findings suggested that one mechanism by which patients with end-stage renal disease are at increased risk of drug toxicity is reduced activity of the CYP3A enzyme pathway. More... »

PAGES

427-434

Identifiers

URI

http://scigraph.springernature.com/pub.10.1016/s0009-9236(03)00056-0

DOI

http://dx.doi.org/10.1016/s0009-9236(03)00056-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1050158866

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/12732843


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibiotics, Antitubercular", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aryl Hydrocarbon Hydroxylases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Breath Tests", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cytochrome P-450 CYP3A", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Enzyme Induction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Erythromycin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kidney Failure, Chronic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liver", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Oxidoreductases, N-Demethylating", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phenotype", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein Synthesis Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rifampin", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "School of Pharmacy, and the Department of Medicine, Division of Nephrology, School of Medicine, University of Maryland Pharmacokinetics/Biopharmaceutics Laboratory Baltimore Md USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dowling", 
        "givenName": "Thomas C.", 
        "id": "sg:person.01074650666.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01074650666.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "School of Pharmacy, and the Department of Medicine, Division of Nephrology, School of Medicine, University of Maryland Pharmacokinetics/Biopharmaceutics Laboratory Baltimore Md USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Briglia", 
        "givenName": "Andrew E.", 
        "id": "sg:person.01311023520.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01311023520.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "School of Pharmacy, and the Department of Medicine, Division of Nephrology, School of Medicine, University of Maryland Pharmacokinetics/Biopharmaceutics Laboratory Baltimore Md USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fink", 
        "givenName": "Jeffrey C.", 
        "id": "sg:person.014470611312.89", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014470611312.89"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "School of Pharmacy, and the Department of Medicine, Division of Nephrology, School of Medicine, University of Maryland Pharmacokinetics/Biopharmaceutics Laboratory Baltimore Md USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hanes", 
        "givenName": "Donna S.", 
        "id": "sg:person.01255251306.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01255251306.02"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "School of Pharmacy, and the Department of Medicine, Division of Nephrology, School of Medicine, University of Maryland Pharmacokinetics/Biopharmaceutics Laboratory Baltimore Md USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Light", 
        "givenName": "Paul D.", 
        "id": "sg:person.01174411442.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174411442.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "School of Pharmacy, and the Department of Medicine, Division of Nephrology, School of Medicine, University of Maryland Pharmacokinetics/Biopharmaceutics Laboratory Baltimore Md USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stackiewicz", 
        "givenName": "Lucy", 
        "id": "sg:person.01122121315.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01122121315.99"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "School of Pharmacy, and the Department of Medicine, Division of Nephrology, School of Medicine, University of Maryland Pharmacokinetics/Biopharmaceutics Laboratory Baltimore Md USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Karyekar", 
        "givenName": "Chetan S.", 
        "id": "sg:person.01132164676.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132164676.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "School of Pharmacy, and the Department of Medicine, Division of Nephrology, School of Medicine, University of Maryland Pharmacokinetics/Biopharmaceutics Laboratory Baltimore Md USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Eddington", 
        "givenName": "Natalie D.", 
        "id": "sg:person.0720701511.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0720701511.28"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "School of Pharmacy, and the Department of Medicine, Division of Nephrology, School of Medicine, University of Maryland Pharmacokinetics/Biopharmaceutics Laboratory Baltimore Md USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Weir", 
        "givenName": "Matthew R.", 
        "id": "sg:person.013452757537.22", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013452757537.22"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "School of Pharmacy, and the Department of Medicine, Division of Nephrology, School of Medicine, University of Maryland Pharmacokinetics/Biopharmaceutics Laboratory Baltimore Md USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Henrich", 
        "givenName": "William L.", 
        "id": "sg:person.01112550337.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01112550337.00"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/0006-2952(84)90451-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000647608"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0006-2952(84)90451-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000647608"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00003088-200140050-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000972929", 
          "https://doi.org/10.2165/00003088-200140050-00002"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00003088-200140050-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000972929", 
          "https://doi.org/10.2165/00003088-200140050-00002"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1086/313548", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003121697"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/j.1875-9114.1998.tb03147.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003751252"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/clpt.1992.174", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003814688", 
          "https://doi.org/10.1038/clpt.1992.174"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/106002809402800303", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005531040"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/106002809402800303", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005531040"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0024-3205(84)90030-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006238852"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0024-3205(84)90030-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006238852"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00005344-198400067-00009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006394194"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00005344-198400067-00009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006394194"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1525-139x.2000.00065.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006505169"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archinte.1982.00340200063016", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006738877"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1016/s0009-9236(99)70130-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009415110", 
          "https://doi.org/10.1016/s0009-9236(99)70130-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/j.1552-4604.1998.tb05785.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010073598"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1016/s0009-9236(98)90055-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012254725", 
          "https://doi.org/10.1016/s0009-9236(98)90055-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.279.15.1200", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018359649"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cpt1974165part1761", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022937647"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0006-291x(84)90723-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023616961"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/10408449209145319", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029820821"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archinte.1995.00430180043006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033106954"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/00912700122010023", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035675560"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00003088-198916040-00001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036734395", 
          "https://doi.org/10.2165/00003088-198916040-00001"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/86882", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040716587", 
          "https://doi.org/10.1038/86882"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/86882", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040716587", 
          "https://doi.org/10.1038/86882"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/j.1875-9114.1998.tb03830.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040917069"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/clpt.1992.17", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043265675", 
          "https://doi.org/10.1038/clpt.1992.17"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/00912700022009251", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049688142"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1254/jjp.68.431", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050132807"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1016/0009-9236(95)90261-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053496085", 
          "https://doi.org/10.1016/0009-9236(95)90261-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1067/mcp.2001.119811", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1058147219", 
          "https://doi.org/10.1067/mcp.2001.119811"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.asn.0000017575.50319.77", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060318795"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074548313", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074750911", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082619868", 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-3-0348-7292-8_13", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1089814061", 
          "https://doi.org/10.1007/978-3-0348-7292-8_13"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2003-05", 
    "datePublishedReg": "2003-05-01", 
    "description": "BACKGROUND: The cytochrome p450 (CYP) oxidative enzyme system, located primarily in the liver and small intestine, is responsible for metabolism and detoxification of numerous endogenous and exogenous substances. The most abundant CYP enzyme, CYP3A, is known to be involved in the metabolism of more than 200 commonly used medications. In experimental models of renal failure, both hepatic function and CYP enzyme content are reduced; however, direct evidence in humans is lacking. Evaluation of drug metabolism in patients with end-stage renal disease is important because these patients use a large number of medications and are at risk of adverse reactions and drug-drug interactions.\nMETHODS: We measured hepatic CYP3A activity at baseline and after rifampin (INN, rifampicin) enzyme induction in 12 patients with end-stage renal disease and 12 healthy, age-matched controls. Hepatic CYP3A phenotype was characterized with the erythromycin breath test, and enzyme induction capacity was evaluated with a short course of rifampin (600 mg/d for 6 days).\nRESULTS: The end-stage renal disease group had 28% lower baseline erythromycin breath test values than controls (P <.05); however, enzyme induction capacity after rifampin administration was similar between groups (P =.70).\nCONCLUSION: The findings suggested that one mechanism by which patients with end-stage renal disease are at increased risk of drug toxicity is reduced activity of the CYP3A enzyme pathway.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1016/s0009-9236(03)00056-0", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1017409", 
        "issn": [
          "0009-9236", 
          "1532-6535"
        ], 
        "name": "Clinical Pharmacology & Therapeutics", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "73"
      }
    ], 
    "name": "Characterization of hepatic cytochrome P4503A activity in patients with end\u2010stage renal disease", 
    "pagination": "427-434", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "eef10939efdfbaa1415d6c579be8aec3e8e0c7daf708ff8593d86a4e3049c056"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "12732843"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0372741"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1016/s0009-9236(03)00056-0"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1050158866"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1016/s0009-9236(03)00056-0", 
      "https://app.dimensions.ai/details/publication/pub.1050158866"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T17:08", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8672_00000274.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://onlinelibrary.wiley.com/doi/10.1016/S0009-9236(03)00056-0/abstract"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1016/s0009-9236(03)00056-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1016/s0009-9236(03)00056-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1016/s0009-9236(03)00056-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1016/s0009-9236(03)00056-0'


 

This table displays all metadata directly associated to this object as RDF triples.

328 TRIPLES      21 PREDICATES      80 URIs      40 LITERALS      28 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1016/s0009-9236(03)00056-0 schema:about N32c160c5f7304f22bb735db887d02075
2 N524602265b2c4a1f81272c0370b3b34b
3 N70db124b0f8b4ed4a47a0372d0c85a02
4 N7240b98341d3497dbdebf53e3e713f3e
5 N766dad6e6b8148be84a9c1ba4877b5c7
6 N7a82acc345e3480a908a51ad4f8b68ba
7 N7b33e863219c4b50b1a3a718661597eb
8 N8137956c2c6d4633917918cb7f4302c6
9 N83d19ac19b0147be848445ca57d42cc5
10 N9a383c6993a240af938a9ef74b0b6d38
11 N9ba50328c6114244a6b67269e8d4fe52
12 N9e36428f6b3f4d3f95ff91080c8d2f28
13 Na00f6d0bb2404bd0a1b4291ab555569e
14 Na50e814d452a46f38239fe6d4ff25279
15 Na60334ba6b28489095a7205537938335
16 Nae21cea36aa0483da6a67c5e9c9f6d62
17 Nc1fd6e39042e469f93440f56384c0f0f
18 Nf18c4c71ed0b4e94ac0a164f35de6660
19 Nf2526a9e53584729a3601ab3abf68be2
20 anzsrc-for:11
21 anzsrc-for:1103
22 schema:author N0724f4339afe48668b6b0429ecd6c0c0
23 schema:citation sg:pub.10.1007/978-3-0348-7292-8_13
24 sg:pub.10.1016/0009-9236(95)90261-9
25 sg:pub.10.1016/s0009-9236(98)90055-8
26 sg:pub.10.1016/s0009-9236(99)70130-x
27 sg:pub.10.1038/86882
28 sg:pub.10.1038/clpt.1992.17
29 sg:pub.10.1038/clpt.1992.174
30 sg:pub.10.1067/mcp.2001.119811
31 sg:pub.10.2165/00003088-198916040-00001
32 sg:pub.10.2165/00003088-200140050-00002
33 https://app.dimensions.ai/details/publication/pub.1074548313
34 https://app.dimensions.ai/details/publication/pub.1074750911
35 https://app.dimensions.ai/details/publication/pub.1082619868
36 https://doi.org/10.1001/archinte.1982.00340200063016
37 https://doi.org/10.1001/archinte.1995.00430180043006
38 https://doi.org/10.1001/jama.279.15.1200
39 https://doi.org/10.1002/cpt1974165part1761
40 https://doi.org/10.1002/j.1552-4604.1998.tb05785.x
41 https://doi.org/10.1002/j.1875-9114.1998.tb03147.x
42 https://doi.org/10.1002/j.1875-9114.1998.tb03830.x
43 https://doi.org/10.1016/0006-291x(84)90723-x
44 https://doi.org/10.1016/0006-2952(84)90451-9
45 https://doi.org/10.1016/0024-3205(84)90030-4
46 https://doi.org/10.1046/j.1525-139x.2000.00065.x
47 https://doi.org/10.1086/313548
48 https://doi.org/10.1097/00005344-198400067-00009
49 https://doi.org/10.1097/01.asn.0000017575.50319.77
50 https://doi.org/10.1177/00912700022009251
51 https://doi.org/10.1177/00912700122010023
52 https://doi.org/10.1177/106002809402800303
53 https://doi.org/10.1254/jjp.68.431
54 https://doi.org/10.3109/10408449209145319
55 schema:datePublished 2003-05
56 schema:datePublishedReg 2003-05-01
57 schema:description BACKGROUND: The cytochrome p450 (CYP) oxidative enzyme system, located primarily in the liver and small intestine, is responsible for metabolism and detoxification of numerous endogenous and exogenous substances. The most abundant CYP enzyme, CYP3A, is known to be involved in the metabolism of more than 200 commonly used medications. In experimental models of renal failure, both hepatic function and CYP enzyme content are reduced; however, direct evidence in humans is lacking. Evaluation of drug metabolism in patients with end-stage renal disease is important because these patients use a large number of medications and are at risk of adverse reactions and drug-drug interactions. METHODS: We measured hepatic CYP3A activity at baseline and after rifampin (INN, rifampicin) enzyme induction in 12 patients with end-stage renal disease and 12 healthy, age-matched controls. Hepatic CYP3A phenotype was characterized with the erythromycin breath test, and enzyme induction capacity was evaluated with a short course of rifampin (600 mg/d for 6 days). RESULTS: The end-stage renal disease group had 28% lower baseline erythromycin breath test values than controls (P <.05); however, enzyme induction capacity after rifampin administration was similar between groups (P =.70). CONCLUSION: The findings suggested that one mechanism by which patients with end-stage renal disease are at increased risk of drug toxicity is reduced activity of the CYP3A enzyme pathway.
58 schema:genre research_article
59 schema:inLanguage en
60 schema:isAccessibleForFree false
61 schema:isPartOf N0cfd4f6c59304ce9863b1415b1309838
62 Na53d395a336c4d37b53782c081ffe17e
63 sg:journal.1017409
64 schema:name Characterization of hepatic cytochrome P4503A activity in patients with end‐stage renal disease
65 schema:pagination 427-434
66 schema:productId N61c4dcb5b63849108a1db189e068b96b
67 N633ace4fdb6e4680a06904a87bd22cc8
68 N8ebe82ee15954a78819fc9b8526ba497
69 Na35c4b2989e844a1a6b89e3bb0c97d4d
70 Nd3cd5a0e98164062999caa5bbe457f5e
71 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050158866
72 https://doi.org/10.1016/s0009-9236(03)00056-0
73 schema:sdDatePublished 2019-04-10T17:08
74 schema:sdLicense https://scigraph.springernature.com/explorer/license/
75 schema:sdPublisher N1446e9c28d15429e8aa052e0e4936902
76 schema:url http://onlinelibrary.wiley.com/doi/10.1016/S0009-9236(03)00056-0/abstract
77 sgo:license sg:explorer/license/
78 sgo:sdDataset articles
79 rdf:type schema:ScholarlyArticle
80 N0724f4339afe48668b6b0429ecd6c0c0 rdf:first sg:person.01074650666.36
81 rdf:rest Nb0fd2d66ba884d4fa78bd97472ce7ae6
82 N0cfd4f6c59304ce9863b1415b1309838 schema:issueNumber 5
83 rdf:type schema:PublicationIssue
84 N1446e9c28d15429e8aa052e0e4936902 schema:name Springer Nature - SN SciGraph project
85 rdf:type schema:Organization
86 N19ae14eb64df43b1b84d0187b50b316c schema:name School of Pharmacy, and the Department of Medicine, Division of Nephrology, School of Medicine, University of Maryland Pharmacokinetics/Biopharmaceutics Laboratory Baltimore Md USA
87 rdf:type schema:Organization
88 N211fa9b4f2094ea19a5e3f08cf9bf22c rdf:first sg:person.0720701511.28
89 rdf:rest Nbee3984f547a4c7e8fdaa4a4a4d75478
90 N2134ea1c9ae542d89396f8e43c91f88a schema:name School of Pharmacy, and the Department of Medicine, Division of Nephrology, School of Medicine, University of Maryland Pharmacokinetics/Biopharmaceutics Laboratory Baltimore Md USA
91 rdf:type schema:Organization
92 N2ff968f6a8694f6383a70bad1f5841c1 rdf:first sg:person.01132164676.10
93 rdf:rest N211fa9b4f2094ea19a5e3f08cf9bf22c
94 N32c160c5f7304f22bb735db887d02075 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Erythromycin
96 rdf:type schema:DefinedTerm
97 N438792d956564f8bac7a85ce316ef1ba rdf:first sg:person.014470611312.89
98 rdf:rest N6922c0392d254123ac303780ab7fa69e
99 N4eacd6be842e4bab9f34b8ce4dd4e837 schema:name School of Pharmacy, and the Department of Medicine, Division of Nephrology, School of Medicine, University of Maryland Pharmacokinetics/Biopharmaceutics Laboratory Baltimore Md USA
100 rdf:type schema:Organization
101 N50204508534b4a82a78d7c34d82c14ca schema:name School of Pharmacy, and the Department of Medicine, Division of Nephrology, School of Medicine, University of Maryland Pharmacokinetics/Biopharmaceutics Laboratory Baltimore Md USA
102 rdf:type schema:Organization
103 N524602265b2c4a1f81272c0370b3b34b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Kidney Failure, Chronic
105 rdf:type schema:DefinedTerm
106 N61c4dcb5b63849108a1db189e068b96b schema:name doi
107 schema:value 10.1016/s0009-9236(03)00056-0
108 rdf:type schema:PropertyValue
109 N633ace4fdb6e4680a06904a87bd22cc8 schema:name nlm_unique_id
110 schema:value 0372741
111 rdf:type schema:PropertyValue
112 N6922c0392d254123ac303780ab7fa69e rdf:first sg:person.01255251306.02
113 rdf:rest N87c086f7bc9f4fed853fbd963ba02935
114 N6bf501e062254e179158455dfbec41f1 schema:name School of Pharmacy, and the Department of Medicine, Division of Nephrology, School of Medicine, University of Maryland Pharmacokinetics/Biopharmaceutics Laboratory Baltimore Md USA
115 rdf:type schema:Organization
116 N70db124b0f8b4ed4a47a0372d0c85a02 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Phenotype
118 rdf:type schema:DefinedTerm
119 N7240b98341d3497dbdebf53e3e713f3e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Male
121 rdf:type schema:DefinedTerm
122 N766dad6e6b8148be84a9c1ba4877b5c7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Middle Aged
124 rdf:type schema:DefinedTerm
125 N7a82acc345e3480a908a51ad4f8b68ba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Female
127 rdf:type schema:DefinedTerm
128 N7b33e863219c4b50b1a3a718661597eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Protein Synthesis Inhibitors
130 rdf:type schema:DefinedTerm
131 N8004167a49a0460a83fb01f5cd77fd8c schema:name School of Pharmacy, and the Department of Medicine, Division of Nephrology, School of Medicine, University of Maryland Pharmacokinetics/Biopharmaceutics Laboratory Baltimore Md USA
132 rdf:type schema:Organization
133 N8137956c2c6d4633917918cb7f4302c6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Humans
135 rdf:type schema:DefinedTerm
136 N83d19ac19b0147be848445ca57d42cc5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Oxidoreductases, N-Demethylating
138 rdf:type schema:DefinedTerm
139 N87c086f7bc9f4fed853fbd963ba02935 rdf:first sg:person.01174411442.54
140 rdf:rest Nb72c68f06e6a4ff0a07087a7ba06a408
141 N8cafdd58ae184fc89e80b2533f359f2e rdf:first sg:person.01112550337.00
142 rdf:rest rdf:nil
143 N8ebe82ee15954a78819fc9b8526ba497 schema:name dimensions_id
144 schema:value pub.1050158866
145 rdf:type schema:PropertyValue
146 N9a383c6993a240af938a9ef74b0b6d38 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Prospective Studies
148 rdf:type schema:DefinedTerm
149 N9ba50328c6114244a6b67269e8d4fe52 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Liver
151 rdf:type schema:DefinedTerm
152 N9e36428f6b3f4d3f95ff91080c8d2f28 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Aryl Hydrocarbon Hydroxylases
154 rdf:type schema:DefinedTerm
155 Na00f6d0bb2404bd0a1b4291ab555569e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Breath Tests
157 rdf:type schema:DefinedTerm
158 Na35c4b2989e844a1a6b89e3bb0c97d4d schema:name pubmed_id
159 schema:value 12732843
160 rdf:type schema:PropertyValue
161 Na50e814d452a46f38239fe6d4ff25279 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Antibiotics, Antitubercular
163 rdf:type schema:DefinedTerm
164 Na53d395a336c4d37b53782c081ffe17e schema:volumeNumber 73
165 rdf:type schema:PublicationVolume
166 Na551291a38be47febf1e8e2c8a3896e0 schema:name School of Pharmacy, and the Department of Medicine, Division of Nephrology, School of Medicine, University of Maryland Pharmacokinetics/Biopharmaceutics Laboratory Baltimore Md USA
167 rdf:type schema:Organization
168 Na60334ba6b28489095a7205537938335 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Enzyme Induction
170 rdf:type schema:DefinedTerm
171 Nae21cea36aa0483da6a67c5e9c9f6d62 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Adult
173 rdf:type schema:DefinedTerm
174 Nb0fd2d66ba884d4fa78bd97472ce7ae6 rdf:first sg:person.01311023520.23
175 rdf:rest N438792d956564f8bac7a85ce316ef1ba
176 Nb72c68f06e6a4ff0a07087a7ba06a408 rdf:first sg:person.01122121315.99
177 rdf:rest N2ff968f6a8694f6383a70bad1f5841c1
178 Nbbd5a2b7c05342d686a80cc9f51d6aa1 schema:name School of Pharmacy, and the Department of Medicine, Division of Nephrology, School of Medicine, University of Maryland Pharmacokinetics/Biopharmaceutics Laboratory Baltimore Md USA
179 rdf:type schema:Organization
180 Nbee3984f547a4c7e8fdaa4a4a4d75478 rdf:first sg:person.013452757537.22
181 rdf:rest N8cafdd58ae184fc89e80b2533f359f2e
182 Nc1fd6e39042e469f93440f56384c0f0f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Cytochrome P-450 CYP3A
184 rdf:type schema:DefinedTerm
185 Nd3cd5a0e98164062999caa5bbe457f5e schema:name readcube_id
186 schema:value eef10939efdfbaa1415d6c579be8aec3e8e0c7daf708ff8593d86a4e3049c056
187 rdf:type schema:PropertyValue
188 Ne69840f5a6634c2ea038ef87ad1c00fe schema:name School of Pharmacy, and the Department of Medicine, Division of Nephrology, School of Medicine, University of Maryland Pharmacokinetics/Biopharmaceutics Laboratory Baltimore Md USA
189 rdf:type schema:Organization
190 Nf18c4c71ed0b4e94ac0a164f35de6660 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
191 schema:name Aged
192 rdf:type schema:DefinedTerm
193 Nf2526a9e53584729a3601ab3abf68be2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
194 schema:name Rifampin
195 rdf:type schema:DefinedTerm
196 Nf5da56bed15942c0a1767f88b195aff6 schema:name School of Pharmacy, and the Department of Medicine, Division of Nephrology, School of Medicine, University of Maryland Pharmacokinetics/Biopharmaceutics Laboratory Baltimore Md USA
197 rdf:type schema:Organization
198 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
199 schema:name Medical and Health Sciences
200 rdf:type schema:DefinedTerm
201 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
202 schema:name Clinical Sciences
203 rdf:type schema:DefinedTerm
204 sg:journal.1017409 schema:issn 0009-9236
205 1532-6535
206 schema:name Clinical Pharmacology & Therapeutics
207 rdf:type schema:Periodical
208 sg:person.01074650666.36 schema:affiliation N6bf501e062254e179158455dfbec41f1
209 schema:familyName Dowling
210 schema:givenName Thomas C.
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01074650666.36
212 rdf:type schema:Person
213 sg:person.01112550337.00 schema:affiliation N2134ea1c9ae542d89396f8e43c91f88a
214 schema:familyName Henrich
215 schema:givenName William L.
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01112550337.00
217 rdf:type schema:Person
218 sg:person.01122121315.99 schema:affiliation N50204508534b4a82a78d7c34d82c14ca
219 schema:familyName Stackiewicz
220 schema:givenName Lucy
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01122121315.99
222 rdf:type schema:Person
223 sg:person.01132164676.10 schema:affiliation Nbbd5a2b7c05342d686a80cc9f51d6aa1
224 schema:familyName Karyekar
225 schema:givenName Chetan S.
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132164676.10
227 rdf:type schema:Person
228 sg:person.01174411442.54 schema:affiliation Ne69840f5a6634c2ea038ef87ad1c00fe
229 schema:familyName Light
230 schema:givenName Paul D.
231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174411442.54
232 rdf:type schema:Person
233 sg:person.01255251306.02 schema:affiliation N8004167a49a0460a83fb01f5cd77fd8c
234 schema:familyName Hanes
235 schema:givenName Donna S.
236 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01255251306.02
237 rdf:type schema:Person
238 sg:person.01311023520.23 schema:affiliation N19ae14eb64df43b1b84d0187b50b316c
239 schema:familyName Briglia
240 schema:givenName Andrew E.
241 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01311023520.23
242 rdf:type schema:Person
243 sg:person.013452757537.22 schema:affiliation Na551291a38be47febf1e8e2c8a3896e0
244 schema:familyName Weir
245 schema:givenName Matthew R.
246 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013452757537.22
247 rdf:type schema:Person
248 sg:person.014470611312.89 schema:affiliation Nf5da56bed15942c0a1767f88b195aff6
249 schema:familyName Fink
250 schema:givenName Jeffrey C.
251 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014470611312.89
252 rdf:type schema:Person
253 sg:person.0720701511.28 schema:affiliation N4eacd6be842e4bab9f34b8ce4dd4e837
254 schema:familyName Eddington
255 schema:givenName Natalie D.
256 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0720701511.28
257 rdf:type schema:Person
258 sg:pub.10.1007/978-3-0348-7292-8_13 schema:sameAs https://app.dimensions.ai/details/publication/pub.1089814061
259 https://doi.org/10.1007/978-3-0348-7292-8_13
260 rdf:type schema:CreativeWork
261 sg:pub.10.1016/0009-9236(95)90261-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053496085
262 https://doi.org/10.1016/0009-9236(95)90261-9
263 rdf:type schema:CreativeWork
264 sg:pub.10.1016/s0009-9236(98)90055-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012254725
265 https://doi.org/10.1016/s0009-9236(98)90055-8
266 rdf:type schema:CreativeWork
267 sg:pub.10.1016/s0009-9236(99)70130-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1009415110
268 https://doi.org/10.1016/s0009-9236(99)70130-x
269 rdf:type schema:CreativeWork
270 sg:pub.10.1038/86882 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040716587
271 https://doi.org/10.1038/86882
272 rdf:type schema:CreativeWork
273 sg:pub.10.1038/clpt.1992.17 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043265675
274 https://doi.org/10.1038/clpt.1992.17
275 rdf:type schema:CreativeWork
276 sg:pub.10.1038/clpt.1992.174 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003814688
277 https://doi.org/10.1038/clpt.1992.174
278 rdf:type schema:CreativeWork
279 sg:pub.10.1067/mcp.2001.119811 schema:sameAs https://app.dimensions.ai/details/publication/pub.1058147219
280 https://doi.org/10.1067/mcp.2001.119811
281 rdf:type schema:CreativeWork
282 sg:pub.10.2165/00003088-198916040-00001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036734395
283 https://doi.org/10.2165/00003088-198916040-00001
284 rdf:type schema:CreativeWork
285 sg:pub.10.2165/00003088-200140050-00002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000972929
286 https://doi.org/10.2165/00003088-200140050-00002
287 rdf:type schema:CreativeWork
288 https://app.dimensions.ai/details/publication/pub.1074548313 schema:CreativeWork
289 https://app.dimensions.ai/details/publication/pub.1074750911 schema:CreativeWork
290 https://app.dimensions.ai/details/publication/pub.1082619868 schema:CreativeWork
291 https://doi.org/10.1001/archinte.1982.00340200063016 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006738877
292 rdf:type schema:CreativeWork
293 https://doi.org/10.1001/archinte.1995.00430180043006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033106954
294 rdf:type schema:CreativeWork
295 https://doi.org/10.1001/jama.279.15.1200 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018359649
296 rdf:type schema:CreativeWork
297 https://doi.org/10.1002/cpt1974165part1761 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022937647
298 rdf:type schema:CreativeWork
299 https://doi.org/10.1002/j.1552-4604.1998.tb05785.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1010073598
300 rdf:type schema:CreativeWork
301 https://doi.org/10.1002/j.1875-9114.1998.tb03147.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1003751252
302 rdf:type schema:CreativeWork
303 https://doi.org/10.1002/j.1875-9114.1998.tb03830.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1040917069
304 rdf:type schema:CreativeWork
305 https://doi.org/10.1016/0006-291x(84)90723-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1023616961
306 rdf:type schema:CreativeWork
307 https://doi.org/10.1016/0006-2952(84)90451-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000647608
308 rdf:type schema:CreativeWork
309 https://doi.org/10.1016/0024-3205(84)90030-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006238852
310 rdf:type schema:CreativeWork
311 https://doi.org/10.1046/j.1525-139x.2000.00065.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1006505169
312 rdf:type schema:CreativeWork
313 https://doi.org/10.1086/313548 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003121697
314 rdf:type schema:CreativeWork
315 https://doi.org/10.1097/00005344-198400067-00009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006394194
316 rdf:type schema:CreativeWork
317 https://doi.org/10.1097/01.asn.0000017575.50319.77 schema:sameAs https://app.dimensions.ai/details/publication/pub.1060318795
318 rdf:type schema:CreativeWork
319 https://doi.org/10.1177/00912700022009251 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049688142
320 rdf:type schema:CreativeWork
321 https://doi.org/10.1177/00912700122010023 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035675560
322 rdf:type schema:CreativeWork
323 https://doi.org/10.1177/106002809402800303 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005531040
324 rdf:type schema:CreativeWork
325 https://doi.org/10.1254/jjp.68.431 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050132807
326 rdf:type schema:CreativeWork
327 https://doi.org/10.3109/10408449209145319 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029820821
328 rdf:type schema:CreativeWork
 




Preview window. Press ESC to close (or click here)


...